EXPIRES at 11:59pm: Full Transcript of Our Urgent Broadcast on India's Revival
Here is the latest financial fact sheet of Lupin. For more details, see the Lupin quarterly results and Lupin share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | 0.6 |
No. of shares | m | 452.65 |
% ch week | % | 0.7 |
% ch 1-mth | % | -0.5 |
% ch 12-mth | % | 30.3 |
52 week H/L | Rs | 1,121.9/787.6 |
No. of Mths Year Ending |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
5-Yr Chart Click to enlarge
|
---|
LUPIN EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 2,127 | 1,750 | 1,465 | 986 | 882 | |
Low | Rs | 1,294 | 1,384 | 727 | 720 | 505 | |
Sales per share (Unadj.) | Rs | 316.4 | 387.4 | 349.6 | 324.1 | 339.4 | |
Earnings per share (Unadj.) | Rs | 50.2 | 56.6 | 5.6 | 13.4 | -5.9 | |
Diluted earnings per share | Rs | 49.9 | 56.5 | 5.6 | 13.4 | -6.0 | |
Cash flow per share (Unadj.) | Rs | 61.0 | 76.8 | 29.6 | 32.1 | 15.5 | |
Dividends per share (Unadj.) | Rs | 7.50 | 7.50 | 5.00 | 5.00 | 6.00 | |
Adj. dividends per share | Rs | 7.47 | 7.48 | 4.99 | 5.00 | 6.00 | |
Dividend yield (eoy) | % | 0.4 | 0.5 | 0.5 | 0.6 | 0.9 | |
Book value per share (Unadj.) | Rs | 247.8 | 298.9 | 300.3 | 303.7 | 276.7 | |
Adj. book value per share | Rs | 246.6 | 298.2 | 299.9 | 303.6 | 277.0 | |
Shares outstanding (eoy) | m | 450.58 | 451.58 | 452.08 | 452.49 | 453.00 | |
Bonus/Rights/Conversions | - | ESOP | ESOP | ESOP | ESOP | ||
Price / Sales ratio | x | 5.4 | 4.0 | 3.1 | 2.6 | 2.0 | |
Avg P/E ratio | x | 34.1 | 27.7 | 197.2 | 63.6 | -116.6 | |
P/CF ratio (eoy) | x | 28.0 | 20.4 | 37.1 | 26.6 | 44.8 | |
Price / Book Value ratio | x | 6.9 | 5.2 | 3.6 | 2.8 | 2.5 | |
Dividend payout | % | 14.9 | 13.2 | 90.0 | 37.3 | -100.9 | |
Avg Mkt Cap | Rs m | 770,740 | 707,513 | 495,502 | 386,064 | 314,201 | |
No. of employees | `000 | 16.4 | 16.8 | 17.0 | 17.7 | 18.3 | |
Total wages/salary | Rs m | 21,416 | 28,495 | 28,647 | 27,702 | 29,868 | |
Avg. sales/employee | Rs Th | 8,718.5 | 10,418.3 | 9,273.6 | 8,292.6 | 8,400.6 | |
Avg. wages/employee | Rs Th | 1,309.8 | 1,697.0 | 1,681.0 | 1,566.5 | 1,632.0 | |
Avg. net profit/employee | Rs Th | 1,382.6 | 1,523.0 | 147.4 | 343.0 | -147.2 |
LUPIN INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 142,555 | 174,943 | 158,042 | 146,646 | 153,748 | |
Other income | Rs m | 1,852 | 1,065 | 1,504 | 3,330 | 4,838 | |
Total revenues | Rs m | 144,407 | 176,008 | 159,545 | 149,976 | 158,585 | |
Gross profit | Rs m | 36,854 | 44,931 | 31,475 | 26,552 | 24,849 | |
Depreciation | Rs m | 4,871 | 9,122 | 10,859 | 8,461 | 9,702 | |
Interest | Rs m | 595 | 1,525 | 2,044 | 3,025 | 3,630 | |
Profit before tax | Rs m | 33,239 | 35,349 | 20,076 | 18,397 | 16,355 | |
Minority Interest | Rs m | -88 | -72 | -71 | -89 | 4 | |
Prior Period Items | Rs m | 49 | 83 | 35 | 38 | 39 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | -14,644 | -3,400 | -7,521 | |
Tax | Rs m | 10,593 | 9,785 | 2,885 | 8,879 | 11,571 | |
Profit after tax | Rs m | 22,607 | 25,575 | 2,513 | 6,066 | -2,694 | |
Gross profit margin | % | 25.9 | 25.7 | 19.9 | 18.1 | 16.2 | |
Effective tax rate | % | 31.9 | 27.7 | 14.4 | 48.3 | 70.8 | |
Net profit margin | % | 15.9 | 14.6 | 1.6 | 4.1 | -1.8 |
LUPIN BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 98,874 | 119,529 | 122,095 | 138,536 | 154,132 | |
Current liabilities | Rs m | 50,612 | 61,206 | 50,956 | 61,299 | 92,252 | |
Net working cap to sales | % | 33.9 | 33.3 | 45.0 | 52.7 | 40.2 | |
Current ratio | x | 2.0 | 2.0 | 2.4 | 2.3 | 1.7 | |
Inventory Days | Days | 84 | 76 | 85 | 95 | 82 | |
Debtors Days | Days | 116 | 90 | 120 | 128 | 129 | |
Net fixed assets | Rs m | 114,194 | 131,660 | 129,876 | 127,516 | 89,082 | |
Share capital | Rs m | 901 | 903 | 904 | 905 | 906 | |
"Free" reserves | Rs m | 110,733 | 134,073 | 134,866 | 136,517 | 124,461 | |
Net worth | Rs m | 111,634 | 134,976 | 135,771 | 137,422 | 125,367 | |
Long term debt | Rs m | 53,739 | 56,478 | 64,245 | 66,417 | 17,933 | |
Total assets | Rs m | 226,249 | 266,073 | 263,054 | 279,494 | 249,839 | |
Interest coverage | x | 56.9 | 24.2 | 10.8 | 7.1 | 5.5 | |
Debt to equity ratio | x | 0.5 | 0.4 | 0.5 | 0.5 | 0.1 | |
Sales to assets ratio | x | 0.6 | 0.7 | 0.6 | 0.5 | 0.6 | |
Return on assets | % | 10.3 | 10.2 | 1.7 | 3.3 | 0.4 | |
Return on equity | % | 20.3 | 18.9 | 1.9 | 4.4 | -2.1 | |
Return on capital | % | 20.4 | 19.3 | 3.7 | 8.8 | 8.7 | |
Exports to sales | % | 47.2 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 7.2 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 67,244 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 10,199 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 71,405 | 81,885 | 53,141 | 59,414 | 51,450 | |
Fx outflow | Rs m | 17,807 | 21,506 | 19,335 | 22,282 | 19,470 | |
Net fx | Rs m | 53,598 | 60,378 | 33,807 | 37,132 | 31,980 |
LUPIN CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -3,824 | 41,135 | 17,512 | 16,660 | 14,688 | |
From Investments | Rs m | -69,617 | -25,274 | 4,699 | -32,825 | 11,070 | |
From Financial Activity | Rs m | 58,364 | 4,332 | -14,921 | 7,441 | -8,906 | |
Net Cashflow | Rs m | -15,077 | 20,193 | 7,290 | -8,724 | 16,853 |
Share Holding
|
Company Information
|
CHM: D. B. Gupta | COMP SEC: R. V. Satam | YEAR OF INC: 1983 | BSE CODE: 500257 | FV (Rs): 2 | DIV YIELD (%): 0.6 |
Read: LUPIN 2019-20 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: WYETH TTK HEALTHCARE PANACEA BIOTECH ALKEM LABORATORIES SUVEN LIFE SCIENCES
Compare LUPIN With: WYETH TTK HEALTHCARE PANACEA BIOTECH ALKEM LABORATORIES SUVEN LIFE SCIENCES
Compare LUPIN With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US) TEVA PHARMA (Israel)
Indian share markets ended on a flat note on Friday. Benchmark indices gave up early gains during closing hours on Friday as investors worried about the surge in Covid cases in the country
Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.
For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.
For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.
Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More